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Abstract
CD4
+ T cells are essential for the control of Yersinia enterocolitica (Ye) infection in mice. Ye can inhibit dendritic cell (DC)
antigen uptake and degradation, maturation and subsequently T-cell activation in vitro. Here we investigated the effects of
Ye infection on splenic DCs and T-cell proliferation in an experimental mouse infection model. We found that OVA-specific
CD4
+ T cells had a reduced potential to proliferate when stimulated with OVA after infection with Ye compared to control
mice. Additionally, proliferation of OVA-specific CD4
+ T cells was markedly reduced when cultured with splenic CD8a
+ DCs
from Ye infected mice in the presence of OVA. In contrast, T-cell proliferation was not impaired in cultures with CD4
+ or
CD4
2CD8a
2 DCs isolated from Ye infected mice. However, OVA uptake and degradation as well as cytokine production
were impaired in CD8a
+ DCs, but not in CD4
+ and CD4
2CD8a
2 DCs after Ye infection. Pathogenicity factors (Yops) from Ye
were most frequently injected into CD8a
+ DCs, resulting in less MHC class II and CD86 expression than on non-injected
CD8a
+ DCs. Three days post infection with Ye the number of splenic CD8a
+ and CD4
+ DCs was reduced by 50% and 90%,
respectively. The decreased number of DC subsets, which was dependent on TLR4 and TRIF signaling, was the result of a
faster proliferation and suppressed de novo DC generation. Together, we show that Ye infection negatively regulates the
stimulatory capacity of some but not all splenic DC subpopulations in vivo. This leads to differential antigen uptake and
degradation, cytokine production, cell loss, and cell death rates in various DC subpopulations. The data suggest that these
effects might be caused directly by injection of Yops into DCs and indirectly by affecting the homeostasis of CD4
+ and
CD8a
+ DCs. These events may contribute to reduced T-cell proliferation and immune evasion of Ye.
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Introduction
Host defense against microbial pathogens relies on the
concerted action of both antigen-independent innate immunity
and antigen-specific adaptive immunity [1–3]. Key features of the
innate immune system include the ability to rapidly recognize
pathogens and/or tissue injury and to signal the presence of
danger to cells of the adaptive immune system [4]. Innate immune
cells use a variety of receptors to recognize patterns shared
between pathogens, e.g. bacterial LPS [5–7].
Dendritic cells (DCs) are unique antigen presenting cells that are
able to induce primary immune responses, thus permitting the
establishment of immunological memory [8–11]. Immature DCs
are specialized to endocytose antigens [11]. Engagement of toll-like
receptors (TLRs) expressed by DCs induces maturation and
migration of DCs to secondary lymphoid organs where the antigens
are presented to T cells in order to initiate adaptive immune
responses. DC maturation is associated with reduced antigen
uptake, up-regulation of MHC class II and costimulatory molecules
and increased ability to prime T cells [12,13]. Mouse splenic
conventional CD11c
hi DCs can be subdivided according to surface
marker expression into CD4
+, CD8a
+, and CD4
2CD8a
2 DCs
[14]. The administration of LPS in mice causes migration of CD4
+,
CD8a
+, and CD4
2CD8a
2DCs from the marginal zone into the T-
cell zones of the spleen and is associated with apoptosis of DCs [15–
17]. All splenic DC subpopulations can prime naı ¨ve T cells. CD8a
+
DCs induce predominantly Th1 responses, while CD8a
2 DCs
promote Th2responses[18].CD8a
+ DCsseem tobe specialized for
priming cytotoxic CD8
+ T cells [19,20].
Yersinia enterocolitica (Ye) is a Gram-negative predominantly
extracellularly located bacterium that causes food borne acute or
chronic gastrointestinal and systemic diseases [21]. Ye invades
through M cells of the Peyer’s Patches and may eventually
disseminate to the lymph nodes, spleen, lung, and liver. The
PLoS Pathogens | www.plospathogens.org 1 November 2010 | Volume 6 | Issue 11 | e1001212pathogenicity of Ye depends on the type three secretion system
(TTSS) by which virulence factors, the so-called Yersinia outer
proteins (Yops) are injected into the cytosol of host cells [22].
YopE, YopT and YopO modulate the cytoskeleton of the host
cells, and YopH dephosphorylates focal adhesion molecules
thereby inhibiting phagocytosis [23–26]. YopP inhibits NF-kB
and MAP kinase signaling pathways and induces apoptosis in
macrophages and bone marrow-derived DCs (BM-DCs) in vitro
[27–33].
Based on an experimental Ye mouse infection model it was
demonstrated that CD4
+ and CD8
+ T cells are required for
control of Ye infection. Accordingly, T-cell deficient mice do not
control Ye and die from a fulminant infection. Moreover, the
adoptive transfer of Ye-specific CD4
+ or CD8
+ T cells into T-cell
deficient mice confers protection against Ye infection [34,35].
IFN-c, TNF, IL-12 and IL-18 are essential for the control of Ye
infection [36–39], suggesting a critical role of Th1 responses that
may activate macrophages via IFN-c production.
In previous in vitro studies we could show that Ye modulates
specific immune functions of BM-DCs including their maturation
[27], antigen uptake [40], processing [41] and subsequently CD4
+
T-cell activation [27] by Yop injection. YopP induces apoptosis via
the activation of caspases, and triggers caspase-independent
necrosis in BM-DCs [27,33]. Moreover, Ye YopP inhibits the
up-regulation of costimulatory molecules and the production of
proinflammatory cytokines [27]. It was also shown that YopP
impairs clathrin-mediated endocytosis by BM-DCs and antigen
degradation [40,41]. Thus, Ye, particularly YopP, inhibits many
functions of BM-DCs in vitro. However, Ye infection is usually a
self-limiting disease and the question arises whether such profound
inhibition of DC functions also occurs upon Ye infection in vivo.
Furthermore, disruption of YopP in Ye does not significantly affect
virulence of Ye in vivo thereby challenging the physiological
relevance of the observations obtained by BM-DCs based in vitro
studies [42]. In this study we analyzed the effect of Ye infection on
splenic DC subpopulations. Our data show a functionally
impaired CD8a
+ DC subset regarding antigen uptake and
processing associated with a reduced ability to activate CD4
+ T
cells. Moreover, Ye infection directly affected a major fraction of
splenic DCs by injection of Yops leading to reduced expression of
MHC class II and CD86 on CD8a
+ DCs. Finally Ye infection
caused a TLR4-TRIF-dependent indirect loss of CD4
+ and
CD8a
+ DCs, which resulted from faster proliferation and inhibited
de novo generation of these DC subpopulations.
Results
Ye reduces CD4
+ T cell proliferation in vivo
T-cell responses are essential for the elimination of Ye [34,35].
Accordingly, an increasing body of evidence derived from in vitro
studies indicates that Yersinia may evade immune response by
targeting DCs which are essential for triggering T-cell responses.
To address whether Ye infection alters the capacity of DCs to
induce T-cell proliferation in vivo, mice were infected with Ye wild
type strain pYV
+ followed by adoptive transfer of CFSE-labeled
CD4
+ T cells from anti-ovalbumin (OVA) T-cell receptor
transgenic mice [43]. 24 h post infection (p.i.) OVA protein was
injected intravenously (i.v.) into the mice. CFSE-dilution of
proliferating CD4
+ T cells was analyzed by flow cytometry three
days later. OVA-specific CFSE-labeled CD4
+ T cells showed no
signs of proliferation in the absence of OVA after in vivo transfer.
Infection of mice with Ye significantly reduced the number of
proliferating antigen-specific T cells in vivo compared to that of
PBS-injected control mice (Fig. 1A). Quantitative analysis of
CFSE-dilution revealed a significant reduction of the division of
OVA-specific CFSE-labeled CD4
+ T cells from Ye-infected mice
compared to PBS-treated mice (Fig. 1A). These data suggested
that Ye affects the ability of DCs to activate CD4
+ T cells in vivo.
To test whether a deficient DC maturation is responsible for the
impaired T-cell proliferation, splenic CD4
+, CD8a
+, and
CD4
2CD8a
2 DC subpopulations were sorted 24 h p.i. with Ye
and co-cultured with OVA-specific CFSE-labeled CD4
+ T cells in
the presence of OVA protein (Fig. 1B) or OVA peptide (Fig. 1C).
CD8a
+ DCs from PBS-treated mice showed more pronounced
CD4
+ T-cell proliferation than CD4
+ and CD4
2CD8a
2 DCs
when co-cultured with OVA protein. Interestingly, the Yersinia
infection significantly reduced the proliferation of the OVA-
specific CD4
+ T cells co-cultured with OVA protein (p=0.0047)
or peptide-pulsed (p=0.037) CD8a
+ DCs. In contrast, the T-cell
proliferation capacity of CD4
+ and CD4
2CD8a
2 DCs from Ye
infected mice was unaffected when compared to controls (Fig. 1B
& C). These data suggest that Ye affects antigen uptake and/or
processing by and maturation of CD8a
+ but not CD4
+ and
CD4
2CD8a
2 DCs.
Ye modulates antigen uptake and degradation by DC
subpopulations
To further elucidate whether antigen uptake and/or degradation
by DC subpopulations is modulated by Ye in vivo, mice were co-
injected i.v. 24 h or three days p.i. with AlexaFluor647-labeled
OVA protein to analyze OVA uptake, and DQ-OVA, a self-
quenched fluorescently-labeled OVA protein, which emits fluores-
cence upon proteolytic degradation in endosomes and lysosomes
[41]. OVA uptake and degradation was analyzed 1 h post OVA
administration by flow cytometry. In line with previous data [20],
CD8a
+ DCs displayed a higher uptake of OVA-Alexa647 (Fig. 2A)
than CD4
+ or CD4
2CD8a
2 DCs (Fig. 2A and B). 24 h and three
days p.i. with Ye, we observed 20% or 80% less OVA-
Alexa647
+CD8a
+ DCs, respectively, compared to PBS-treated
mice. The percentage of OVA-Alexa647
+CD4
+ and CD4
2CD8a
2
DCs 24 h post Ye infection was similar to that of PBS-treated mice
(Fig. 2A and B). Interestingly, we found that the percentage of
Author Summary
Dendritic cells (DCs) are crucial in promoting immune
responses against pathogens. Mouse DCs consist of
different subpopulations but their role in immunity to
pathogens and immune evasion is largely unclear. The
enteric pathogen Yersinia enterocolitica (Ye) was shown to
evade DC functions in bone marrow-derived DCs in vitro
inhibiting antigen uptake and degradation, maturation
and subsequently T-cell activation. However, it is contro-
versial whether and, if so, which virulence factors of Ye
(e.g. Yops) contribute to immune evasion of DCs in vivo.
Using an experimental mouse infection model and a b-
lactamase reporter system to track Yop injection into host
cells we demonstrate here for the first time that distinct DC
subpopulations are affected by Ye infection in vivo in
terms of antigen uptake and degradation, cytokine
production, and T-cell proliferation. Moreover, Ye infection
causes the loss of 90% of CD11c
hiCD4
+ DCs in a TLR4- and
TRIF-signaling dependent manner. These data combined
with results reported from infection with e.g. Mycobacte-
rium tuberculosis, Salmonella typhimurium,o rEscherichia
coli suggest that the response of DCs to bacterial
infections is manifold, reflecting the diversity of DC
subpopulations, pathogenicity factors, and life styles of
the pathogens.
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PLoS Pathogens | www.plospathogens.org 2 November 2010 | Volume 6 | Issue 11 | e1001212Figure 1. Infection of mice with Ye reduces CD4 T cell proliferation. (A) C57BL/6 mice were injected i.v. with 5610
4 Ye pYV
+ or PBS. 6 h later
2610
6 CFSE-labeled CD4
+ T cells from OT-II mice were adoptively transferred. 24 h p.i. OVA protein was administered i.v. and T-cell proliferation of
adoptively transferred T cells in the spleen was analyzed 72 h later by flow cytometry. Histograms show CFSE dilution of 7-AAD
2CD4
+Va2
+ cells
representative of three experiments with three mice per group. The percentage of cells below the marker is indicated. The diagram shows the
division index (average number of cell divisions that the responding cells underwent (excluding undivided cells)) of the CD4
+ T cells from PBS treated
and Ye infected mice. The data shown are the summary of three independent experiments with three mice per group. (B&C ) C57BL/6 mice were
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+CD4
+ and CD4
2CD8a
2 DCs was increased 1,5-
to 4-fold three days p.i. with Ye, respectively (Fig. 2A and B).
Furthermore, we determined antigen degradation of DC
subpopulations in vivo by analyzing the percentage of OVA-
Alexa647
+DQ-OVA
+ cells related to all cells, which took up
OVA-Alexa647 after infection of mice with Ye (Fig. 2A upper right
quadrant/upper two quadrants). Overall, 40% of CD4
+ and CD8a
+
DCsfromPBS-treatedmice degradedOVA,incontrastto only15%
ofCD4
2CD8a
2DCs(Fig.2C).24 handthreedaysp.i.ofmicewith
Ye, OVA degradation by CD8a
+ DCs was slightly but significantly
reduced by 15%compared to PBS-treatedmice(Fig. 2C).CD4
+ and
CD4
2CD8a
2 DCs showed similar OVA degradation as PBS-
treated mice 24 h post infection. In contrast, three days post Ye
infection 70% of all OVA-Alexa647
+CD4
+ were also positive for
DQ-OVA, indicating an increase in OVA degradation. Analyzing
the CD4
2CD8a
2 DCs we observed, similar to CD4
+ DCs, an
increase in OVA degradation from 15% to 45%.
Altogether, these data indicate that Ye specifically reduces
antigen uptake and degradation by CD8a
+ DCs, while CD4
+ and
CD4
2CD8a
2 DCs showed an increase in OVA uptake and
degradation three days p.i. with Ye.
Ye induces maturation in DC subpopulations in vivo
As maturation of DCs is induced upon the encounter of danger
signals such as LPS and is essential for T-cell activation, we
analyzed the induction of maturation of DC subpopulations by Ye
upon in vivo infection. Mice were infected with Ye and spleen cells
were subjected to flow cytometry analysis of MHC class II and the
costimulatory molecules CD80, CD86 and CD40 (Fig. 3A). The
expression of MHC class II molecules was up-regulated up to two-
fold 24 h p.i. in all three DC subsets. However, expression of
MHC class II molecules was significantly reduced three days p.i.
compared to 24 h p.i. (Fig. 3B). Similar results were found for
CD8a
+ and CD4
2CD8a
2 DCs in terms of CD80, CD86, and
CD40 expression, and for CD4
+ DCs in terms of CD86
expression. In contrast, no up-regulation of CD40 and only a
slight up-regulation of CD80 was observed for CD4
+ DCs upon
Ye infection (Fig. 3A). Taken together, Ye induces up-regulation of
maturation markers in all splenic cDC subsets 24 h post infection,
but this up-regulation is absent three days post infection.
Consistently, infection of mice for 24 h with Ye resulted in the
increased production of the proinflammatory cytokines IL-12 and
TNF (Fig. 3C) by CD4
+ and CD4
2CD8a
2 DCs compared to
PBS-treated mice. Interestingly, CD8a
+ DCs produced less IL-12
and TNF upon Yersinia infection (Fig. 3C), indicating that Ye
specifically targets this cDC subset. In summary, Ye differentially
affects splenic DC subpopulations in terms of maturation and
cytokine production.
Ye injects bacterial proteins into splenic DCs
Yops are the major pathogenicity factors of Ye and are injected
into host cells via the TTSS. By this means, Ye inhibits
phagocytosis, antigen presentation and both NF-kB and MAPK
signaling cascades [44]. Ko ¨berle et al. and others revealed that Ye,
Y. pseudotuberculosis and Y. pestis preferentially target macrophages,
DCs, and Gr-1
+ cells [45–47]. To analyze whether Ye prefer-
entially targets a splenic DC subpopulation, we adapted a recently
described, new reporter system for monitoring injection of
bacterial proteins into host cells via the TTSS [45,48,49]. We
used Ye wild type strain expressing either a YopE-b-lactamase
fusion protein or YopE-OVA as control for mouse infection
experiments. Spleen cells were stained with the lipophilic CCF4-
AM [50], an esterified form of the CCF4 substrate. After entry into
living cells (Figure S1), cytoplasmic esterases rapidly convert
CCF4-AM into negatively charged CCF4, which is retained in the
cytoplasm. Excitation of CCF4 cumarin residue at 409 nm results
in a fluorescence resonance energy transfer (FRET) to the
fluorescein residue, leading to emission of green fluorescence at
520 nm. Cleavage of CCF4 substrate by b-lactamase interrupts
FRET leading to light emission at 447 nm (blue fluorescence).
Therefore, injection of YopE-b-lactamase by Ye into DCs can be
determined by analyzing the CCF4-green
+blue
+ DCs by flow
cytometry. 24 h p.i. with Ye YopE-b-lactamase mutant strain,
7.161.9% CD11c
hi cells displayed blue fluorescence (Fig. 4A: R1
in dot plots), indicating injection of the YopE-b-lactamase fusion
protein into the cells. No b-lactamase
+ cells (R1) and only
0.160.1% b-lactamase
+ cells (R1) could be detected in mice either
treated with PBS or infected with the control Ye mutant strain
YopE-OVA, respectively. Flow cytometry analysis of the different
DC subpopulations for injection of the YopE-b-lactamase revealed
that significantly more CD8a
+ DCs (11.461.2%) were Yop
injected compared to CD4
+ (6.260.4%) and CD4
2CD8a
2 DCs
(6.460.5%) 24 h p.i. (Fig. 4 A).
To further elucidate direct effects of Yop-injection into the DC
subsets we analyzed the b-lactamase
+ (R1 in Fig. 4A) and b-
lactamase
2 DC subpopulations (R2 in Fig. 4A) from mice infected
with the Ye E40 YopE-b-lactamase mutant strain for their
expression of MHC class II and CD86. Overall, the expression of
these markers by all DC subpopulations from Ye E40 YopE-b-
lactamase mutant strain-infected mice (R1 as well as R2) was
increased compared to DCs from uninfected control mice (Fig. 4B).
These results are similar to that from mice infected with Ye WA-
314 pYV
+ wild type strain (Fig. 3A & B) used in all other
experiments of this study. The expression of MHC class II was
higher (by 15%) in b-lactamase
+CD4
+ and b-lactama-
se
+CD4
2CD8a
2 DCs compared to the b-lactamase
2 cells, while
the MHC class II expression of b-lactamase
+CD8a
+ DCs was 15%
less than that of b-lactamase
2CD8a
+ DCs (Fig. 4B). In contrast,
CD86 expression of b-lactamase
+CD8a
+ and CD4
2CD8a
2 DCs
was reduced by 40% or 15%, respectively, compared to the
corresponding b-lactamase
2 cells. CD86 expression by CD4
+ DCs
was independent of Yop-injection.
In conclusion, Ye directly targets a significant fraction of splenic
DCs, most frequently the CD8a
+ subpopulation, leading to less
expression of MHC class II and CD86 by these Yop-injected cells
when compared to the Yop-uninjected cells.
Ye induces loss of splenic DC subpopulations
Mice treated with LPS or infected with E. coli showed a transient
loss of CD4
+ and CD8a
+ DCs in the spleen by apoptosis [51].
Here, apoptosis was mediated via TLR4 and TRIF signaling. To
elucidate whether Ye induces DC death in vivo, the number of live
and dead splenic DC subpopulations from Ye-infected and PBS-
treated mice were analyzed (Fig. 5). Upon infection with Ye CD4
+
(90%) and to a lesser extent CD8a
+ DCs (65%) were lost (Fig. 5A
and B). Specifically, the number of CD4
+ and CD8a
+ DCs
infected as described in (A). 24 h p.i. CD4
+, CD8a
+, and CD4
2CD8a
2DCs were sorted, and co-cultured in vitro with CFSE-labeled CD4
+ T cells from
OT-II mice without or in the presence of either OVA protein (B) or OVA peptide (C) for 72 h. The percentages of cells below the marker are depicted in
the histograms. The diagrams show the division index of CD4
+ T cells as described in (A). Data show quadruplicates from one out of two independent
experiments. * indicates statistically significant differences.
doi:10.1371/journal.ppat.1001212.g001
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6 cells and 4.7610
5/spleen in PBS-treated
mice to 1610
5 cells and 1.7610
5/spleen three days p.i. with Ye,
respectively (Fig. 5B). In contrast, the number of CD4
2CD8a
2
DCs in the spleen increased upon Ye infection compared to that in
control mice. In addition, we did immunofluorescence microscopy
of cryosections from the spleen of Ye or PBS-treated mice
analyzing the CD11c
+ cells. Ye infection leads to the migration of
CD11c
+ cells from the marginal zone (PBS-treated mice) to the T-
cell zone of the lymphoid follicles and to a reduced number of
CD11c
+ cells three days p.i. (Fig. 6A). CD4 or CD8a down-
regulation on CD4
+ or CD8a
+ DCs was not observed upon
infection of splenocytes with Ye in vitro (Fig. S2), indicating that the
loss of DC subpopulations is not due to simple down-regulation of
these receptors.
We next examined whether the loss of CD4
+ and CD8a
+ DCs is
due to the induction of cell death upon Ye infection. Therefore, we
gated on 7-AAD
+ DC subpopulations because 7-AAD is taken up
by cells with a damaged cell membrane (gating strategy shown in
Fig. S3A and S3B). The percentage of 7-AAD
+CD4
+ DCs
increased from 10% in PBS-treated mice to 44% upon infection
with Ye (Fig. 5C left diagram), whereas the total number of
1.0610
5 7-AAD
+CD4
+ DCs observed in PBS-treated mice was
not increased upon Ye infection (Fig. 5C right diagram). This can
be explained by the decreased number of CD4
+ DCs two and
three days post Ye infection. In line with these data, CD4
+ DCs
displayed an increase in active caspases-3/7
+ cells of 20% upon Ye
infection, compared to 10% in PBS-treated mice (Fig. 5D left
diagram; gating strategy shown in Fig. S3A and S3C). Thus, a
significant increase in the number of caspases-3/7
+CD4
+ DCs
could be observed 24 h post infection. Cell death analyses of
CD8a
+ DCs revealed no increase of 7-AAD
+, but a slight increase
of caspases-3/7
+ DCs 24 h post Ye infection, compared to PBS-
treated mice. Ye induced cell death in CD4
2CD8a
2 DCs as
shown by the increase of the percentage and absolute numbers of
7-AAD
+ and caspases-3/7
+ cells.
Furthermore, we used TUNEL staining for cell death detection
and found a massive increase of TUNEL
+ cells located in Yersinia-
induced abscesses. However, only very few single apoptotic DCs
(CD11c
+TUNEL
+) were found in Yersinia-induced abscesses in the
spleen of infected mice (Fig. 6B), and total numbers of 7-AAD
+
CD4
+ and CD8a
+ DCs were unaltered upon Ye infection and in
PBS-treated control mice.
Hence, Ye-induced apoptosis of CD4
2CD8a
2 DCs results in a
rapid recruitment of the exact same DC subtype during infection
as the population size does not decline. We also observed an
increase in the percentage, but not in total numbers, of cell death
in CD4
+ and CD8a
+ DCs; thus, the Ye-induced loss of CD4
+ and
CD8a
+ DCs in the spleen can only partly be explained by the
induction of apoptosis in these splenic DC subpopulations.
Ye-induced loss of CD4
+ and CD8a
+ DCs is mediated via
TLR4 and TRIF signaling
To elucidate whether the loss of CD4
+and CD8a
+DCs induced by
Ye is due to TLR signaling, we analyzed the number of live and dead
DC subpopulations in the spleen from TLR2
2/2xTLR4
2/2,
MyD88
2/2,a n dTRIF
2/2 mice. Mice were infected with different
doses of Ye to obtain similar bacterial burden in the spleen three days
p.i. (Fig. 7A). Similar to C57BL/6 wild type mice, the number of total
viable CD4
+ and CD8a
+ DCs in MyD88
2/2 mice decreased up to
80% uponYeinfection (Fig. 7B), whereas more or less similar numbers
of these subpopulations could be observed in TLR2
2/2xTLR4
2/2and
TRIF
2/2 m i c e .F u r t h e r m o r e ,t h en u m b e ro fC D 4
2CD8a
2 DCs per
spleen was unchanged upon infection in wild type and MyD88
2/2
mice, but was significantly increased in TLR2
2/2xTLR4
2/2 and
Figure 2. Analysis of antigen uptake and degradation by DCs
from mice infected with Ye. (A–C) C57BL/6 mice were injected i.v.
with 5610
4 Ye pYV
+ or PBS. 24 h or three days p.i. OVA-AlexaFluor647
and DQ-OVA was administered i.v.. Uptake of OVA-AlexaFluor647 and
degradation of DQ-OVA by DC subpopulations in the spleen was
analyzed 1 h later by flow cytometry. (A) Dot plots show OVA-
AlexaFluor647
+ and DQ-OVA
+ DC subpopulations from the mice as
indicated. The percentages of cells in the upper two quadrants are
indicated. (B) The diagram shows the percentage of OVA-Alexa-
Fluor647
+ DC subpopulations as analyzed in (A, upper two quadrants).
(C) DQ-OVA degradation by DC subpopulations was analyzed as the
percentage of cells in the upper right quadrant/percentage of cells in
the two upper quadrants x 100% as shown in A. The data are
representative of 2 experiments with 5 mice per group. * indicates
statistically significant differences.
doi:10.1371/journal.ppat.1001212.g002
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2/2 mice. Hence, Ye-induced loss of CD4
+ and CD8a
+
DCs in wild type mice is mediated via signaling through TLR4 and
TRIF.
Upon Ye infection a dramatic increase of 7-AAD
+CD4
+
DCs was observed in wild type and TRIF
2/2 mice, but not in
TLR2
2/2xTLR4
2/2 and MyD88
2/2 mice (Fig. 7C), indicating
that the induction of cell death in CD4
+ DCs by Ye is mediated via
MyD88 signaling. Ye induces a decrease of CD4
+ DCs by 60% in
MyD88
2/2 mice, while the cell death rate of this population is less
than 10%, indicating that induction of cell death seems not to be
responsible for the observed decrease of CD4
+ DCs.
Increased proliferation and inhibition of de novo
generation of CD4
+ DCs upon Ye infection
To determine whether Ye modulates the proliferation capacity
of DCs, BrdU incorporation into DC subpopulations from
Figure 3. Analysis of DC maturation and cytokine production in mice infected with Ye. (A–C) C57BL/6 mice were injected i.v. with 5610
4
Ye pYV
+ or PBS. 24 h or three days p.i. the expression of MHC class II, CD86, CD80, and CD40 molecules or the production of intracellular cytokines by
DC subpopulations in the spleen was analyzed by flow cytometry. (A) Histograms show expression of the indicated molecules of 7-AAD
2 DC
subpopulations. The diagrams show the mean fluorescence intensity of MHC class II expression (B) or the percentage of each DC subset producing IL-
12 or TNF (C). Data are representative of 2 experiments with 5 mice per group. * indicates statistically significant differences. n.d. not determined.
doi:10.1371/journal.ppat.1001212.g003
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by flow cytometry. As described by others [52,53] CD8a
+ DCs
showed a higher BrdU incorporation than CD4
2CD8a
2 and
CD4
+ DCs (Fig. 8A). Two and three days p.i. with Ye the
percentage of BrdU
+ DC subpopulations was significantly
increased compared to PBS-treated mice. In fact, 81.764.1%
BrdU
+CD4
+ DCs could be observed three days p.i. compared to
37.163.6% in PBS-treated mice. BrdU
+ CD4
2CD8a
2 and
CD8a
+ DCs increased from 40.863.4% to 74.365.1% and
64.262.6% to 80.165.0% 3 days p.i., respectively. In conclusion,
Ye induced a faster proliferation of all DC subpopulations.
All splenic DCs examined in this study originate from the same
precursors. In the bone marrow myeloid precursors (MPs)
differentiate into macrophage and DC precursors (MDPs). They
develop into common DC progenitors (CDPs) and then pre-DCs,
which give exclusively rise to cDCs [54,55]. To analyze whether
the de novo generation of the DC subpopulations in the spleen is
impaired by Ye we used a transgenic mouse model, in which the
DC subpopulations, but not their precursors, were ablated by
diphtheria toxin (DT) treatment [56]. To this end CD11c.DOG
mice were injected once with DT one day prior to Ye infection,
and the number of DC subpopulations was analyzed one to three
days p.i.. In uninfected CD11c.DOG control mice DT treatment
led to 84%, 82%, and 50% reduced numbers of CD4
+, CD8a
+,
and CD4
2CD8a
2 DCs one day after DT treatment, respectively
(Fig. 8B). Four days after DT treatment the number of all DC
subpopulations increased to normal numbers, indicating that all
DCs were recovered in the spleen at this time point. In contrast, in
Ye-infected DT-treated CD11c.DOG mice, the number of CD4
+
DCs did not recover during the period of observation; in fact, the
number of CD4
+ DCs one to three days p.i. was even less than that
of CD11c.DOG mice after DT treatment, indicating that Ye
blocks the de novo generation of CD4
+ DCs. Likewise, the number
of CD8a
+ DCs did not completely recover after Ye infection
compared to PBS-treated mice, whereas the number of
CD4
2CD8a
2 DCs was even increased one to three days p.i.
compared to PBS-treated mice, indicating that Ye infection leads
to an increased de novo generation of CD4
2CD8a
2 DCs. To
exclude the possibility that these CD4
2CD8a
2 DCs were
inflammatory DCs generated from monocytes or monocyte
precursors, CD4
2CD8a
2 DCs from DT-treated CD11c.DOG
mice were analyzed for monocytic markers three days p.i. with Ye
or treatment with PBS (Fig. 8C). The recovered CD4
2CD8a
2
DCs from both Ye-infected as well as PBS-treated mice did not
express either iNOS, CD115 or Ly6C. These markers are
characteristically expressed by TNF and iNOS producing DCs
Figure 4. Injection of Yops into DCs upon infection of mice with Ye. (A&B ) C57BL/6 mice were injected i.v. with 5610
5 Ye E40-YopE53b-
lactamase (YopE-bla), 5610
5 Ye E40-YopE53-OVA (YopE-OVA), or PBS. 24 h p.i. the percentage of DC subpopulations in the spleen injected with YopE-
bla was analyzed by flow cytometry using CCF4 substrate emitting a blue fluorescence when degraded by b-lactamase in the cytosol. (A) The dot
plots show the percentage 6 standard deviation of CCF4-blue
+CD11c
hi cells from mice treated with PBS, infected with the negative control Ye YopE-
OVA mutant strain, or infected with the Ye YopE-bla mutant strain. R1 indicates the blue cells (Yop injected) and R2 the green cells (not injected). The
diagram shows the percentage of blue
+ DC subpopulations of mice infected with the Ye YopE-bla mutant strain. Data shown are the summary of 2
independent experiments with 5–6 mice infected with YopE-bla mutant strain in each experiment. (B) The expression of MHC class II and CD86 on DC
subpopulations from mice injected with PBS or infected with YopE-bla mutant strain was analyzed as described in (A) (R1: blue cells, R2: green cells).
The diagrams show the MHC class II or CD86 expression of the DC subpopulations as mean fluorescence and are representative for 2 independent
experiments with 5–6 mice infected with YopE-bla mutant strain in each experiment. * indicate statistically significant differences.
doi:10.1371/journal.ppat.1001212.g004
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CD4
2CD8a
2 DCs [54]. Taken together, Ye stimulates increased
proliferation of DCs, but higher cell death rates combined with
inhibition of de novo generation lead to loss of CD4
+ and CD8a
+
DC subsets upon infection.
Discussion
Strong efforts were made to elucidate the function of different
splenic DC subsets, but little is known about their roles during
bacterial infections. In previous work, we demonstrated that CD4
+
Figure 5. Analysis of DC subpopulations in mice infected with Ye. (A–D) C57BL/6 mice were injected i.v. with 5610
4 Ye pYV
+ or PBS. (A&B )
24 h to three days p.i. the splenic DC subpopulations stained with antibodies against CD11c, CD4, and CD8 followed by 7-AAD staining were
analyzed by flow cytometry. (A) Dot plots show the gating strategy and the percentages of the viable DC subpopulations in the spleen during
infection of mice with Ye. The data are representative for 5 experiments with 5 mice per group. (B) The diagrams show the percentage (left diagram)
and the total numbers (right diagram) of the indicated DC subpopulations per spleen during infection of mice with Ye. The data are the summary
results of two to 5 experiments with 4–5 mice per group. (C) 24 h to three days p.i. the percentage (left diagram) and the total numbers (right
diagram) of 7-AAD
+ DC subpopulations per spleen were analyzed by flow cytometry. The data are the summary results of two to 5 experiments with
4–5 mice per group. (D) 24 h and three days p.i. the percentage (left diagram) and the total numbers (right diagram) of caspases-3/7
+ DC
subpopulations per spleen were analyzed by flow cytometry. n.d. not determined. Data are representative of 2 independent experiments with 5 mice
per group. * indicate statistically significant differences.
doi:10.1371/journal.ppat.1001212.g005
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bacterial pathogen Ye in mice [34,35] and that Ye modulates DC
functions of BM-DCs in vitro, leading to inhibition of T-cell
proliferation [27,40,41]. However, infection experiments with
BM-DCs can not be used to extrapolate the events operating upon
infection of DCs in vivo because here, distinct DC subsets with
different tissue distribution and functions exist. This study was
aimed to investigate the effects of Ye infection on splenic DC
subsets with respect to antigen uptake, antigen processing, cytokine
production and subsequently T-cell proliferation in vivo.
Strikingly, we found an impaired ability to induce T-cell
proliferation by CD8a
+ but not by CD4
+ or CD4
2CD8a
2 DCs
upon Ye infection in vivo. This is due to a reduction of antigen
uptake and degradation, as well as an inhibition of proinflamma-
tory cytokine secretion. Adoptive transfer experiments with
antigen-pulsed CD8a
+ DCs demonstrated that they promote
Th1 responses, whereas CD8a
2 DCs promote Th2 responses
[18,57,58]. Therefore, targeting of CD8a
+ DCs by Ye may result
in immune evasion of the pathogen as infection control requires
CD4
+ Th1 host responses [34,37]. IL-12 is the key cytokine
responsible for Th1 activation. CD8a
+ DCs have been shown to
produce high levels of IL-12 in vivo upon microbial stimulation or
infection [57,59–63]. On the other hand, CD8a
2 DCs were also
shown to produce IL-12 in response to TLR7 ligands [64] and
LPS in the presence of anti-IL-10 [59]. Upon infection with Ye,
IL-12 as well as TNF production was induced in CD4
+ and
CD4
2CD8a
2, but decreased in CD8a
+ DCs, which in turn may
account for reduced T-cell priming by CD8a
+ DCs.
Macropinocytosis of fluid phase antigen is shown to be down
regulated during DC maturation [65–67]. Ye infection led to a
reduction in OVA uptake by CD8a
+ DCs, which could be either
due to Yop translocation or induction of DC maturation. Several
facts argue against the second possibility: all DC subpopulations
display largely mature phenotypes 24 h p.i. but only the CD8a
+
DCs show reduced OVA uptake. All DC subpopulations display
immature phenotypes 72 h p.i.. At this point OVA uptake by
CD8a
+ DCs was significantly reduced, but increased in CD4
+ and
CD4
2CD8a
2 DCs. As CD8a
+ DCs are considered to be the most
effective splenic DC-type in terms of antigen uptake in vivo [20],
the findings suggest that CD8a
+ DCs are specifically targeted by
Ye. Consistently, OVA uptake was shown to be mediated
predominantly via the macrophage-mannose receptor (MR). This
process is independent of DC maturation [68,69]. The MR is
expressed only by splenic CD8a
+ DCs [68,69] explaining the 3,5–
7 fold higher OVA uptake by CD8a
+ DCs compared to CD4
+ and
CD4
2CD8a
2 DCs in control mice. Previous studies with BM-
DCs showed, that Ye YopP inhibits OVA uptake via receptor-
mediated endocytosis, suggesting a direct effect of Ye on OVA
uptake by CD8a
+ DCs [40]. Whether Ye infection causes a down
regulation of MR is unknown.
DC maturation is crucial for their ability to activate T cells.
Here we found that Ye rapidly induced DC maturation in all DC
subsets, which was absent three days p.i.. This could be due to the
down-regulation of the maturation markers or a rapid turnover of
all DC subsets induced by Ye. In vitro infection of BM-DCs with Ye
revealed an inhibition of DC maturation with respect to expression
Figure 6. Immunofluorescence analysis of DCs from mice infected with Ye. C57BL/6 mice were injected i.v. with 5610
4 Ye pYV
+ or PBS.
(A) Cryosections of spleen from mice treated with PBS or Ye were stained for CD11c (red), Bar =100 mm. (B) Cryosections of spleen from mice treated
with PBS or Ye were stained for CD11c (red, surface staining) and TUNEL (green, nuclear staining). Arrowheads indicate double positive cells, A
abscesses, LF lymphoid follicle.
doi:10.1371/journal.ppat.1001212.g006
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tory cytokine production [27]. These in vitro data differ from the
results in this study, but can be explained by a lesser Yop-injection
rate into DCs in vivo. Usually, up-regulation of maturation markers
is observed upon bacterial infections at different time points, but
their down-regulation is not described [70–73]. De Trez et al.
showed that infection of mice with live or heat-killed apathogenic
E. coli induced maturation of splenic DCs 6 to 9 h p.i. in a TLR4
and TRIF signaling dependent manner [51]. In the present study,
application of heat-killed Ye did not induce maturation of splenic
DCs (data not shown), suggesting that effects other than TLR
activation are responsible for DC maturation in Yersinia infection.
In Salmonella-infected mice, maturation is induced directly in DCs
associated with intracellular Salmonella and indirectly via Salmonella-
induced TNF production [71]. Whether TNF-induced maturation
plays a role in Ye-induced DC maturation has to be further
elucidated. In conclusion, maturation of DCs in vivo is variably
regulated in response to different bacterial pathogens.
We and others could show that Ye, Y. pestis and Y. pseudotuber-
culosis preferentially target professional phagocytes like Gr-1
+ cells,
macrophages, and DCs in vivo by using a b-lactamase reporter
system to detect Yop injection into host cells [45–47]. Ye targets
specifically CD8a
+ DCs, which in turn express less MHC class II
and CD86 than non-injected CD8a
+ DCs. This implies that Ye
induces DC maturation which is then reversed by Yop injection.
In contrast, Yop-injected B cells displayed a significantly increased
expression of CD69 compared to non-Yop-injected B cells,
indicating activation of these cells by Ye [46]. The fact that
CD8a
+ DCs are targeted most frequently by Ye is in agreement
with their impaired OVA uptake and degradation, and cytokine
production leading to less T cell activation. It was shown that
YopH specifically inhibits both T and B cell activation in vitro
[74,75]. Whether Yops secreted into T cells have a direct effect on
T-cell proliferation in vivo remains to be shown. It also remains to
be determined why Yops are specifically injected into CD8a
+ DCs
and how this affects DC functions like cytokine production and T
cell priming in vivo. The DC subsets may differ in their ability to
chemotax towards bacteria. Moreover, as binding of Ye to b1-
integrins is essential for Yop injection [46] the expression of b1-
integrins by DC subsets, could result in the selection for a specific
DC subset.
The reduction in CD4
+ and CD8a
+ DCs in the spleen upon Ye
infection is dependent on TLR4-TRIF signaling. Upon infection
of mice with E. coli or treatment with LPS, the number of CD4
+
and CD8a
+ DCs was markedly reduced 48 hours later [15,51], a
result of TLR4-TRIF signaling induced apoptosis [51]. Recent
findings demonstrate that Type I IFN regulate the turnover of
splenic conventional DCs in vivo [76]. Whether Type I IFNs are
involved in the turnover of conventional DCs upon Ye infection
was not analyzed. Furthermore, oral infection of mice with
Salmonella typhimurium specifically induces death of CD8a
+ DCs, but
not of CD8a
2 DCs, via MyD88 and TNFR1 signaling [77].
However, Ye induced death of predominantly CD4
+ DCs in a
MyD88 dependent manner. Recently it was shown that Y.
pseudotuberculosis induces caspase-1-dependent pyroptosis in acti-
vated macrophages in vivo [78]. Caspase-1 activation might be
responsible for some of the loss of DCs upon Ye infection,
particularly on day 3 p.i. when only a fraction of the 7-AAD
+ cells
are caspase-3/7
+. Unfortunately, the b-lactamase reporter system
can only be used in viable cells and the detection of Yop-injection
into apoptotic cells in vivo is limited.
Here we show for the first time that a bacterial pathogen affects
the homeostasis of specific DC subpopulations. It is likely that the
increased proliferation in combination with the impaired de novo
generation of CD4
+ and CD8a
+ DCs cause the Ye-induced loss of
these DC subpopulations. Recently, Hochweller et al. could show
that DC depletion led to enhanced DC generation as a result of
Figure 7. Analysis of DC subpopulations in TLR2
2/2x4
2/2,
MyD88
2/2, and TRIF
2/2 mice infected with Ye. (A–C)M i c ew e r e
injected i.v. with Ye as follows to achieve a similar bacterial load per spleen:
C57BL/6 and TRIF
2/2with 5610
4pYV
+,T L R 2
2/2x4
2/2with 5610
3pYV
+,a n d
MyD88
2/2with 5610
2pYV
+, or PBS. The diagrams show the bacterial load as
log10colony forming units(CFU) (A), thetotal numbersofDCsubpopulations
(B)a n dt h ep e r c e n t a g e( C)o f7 - A A D
+ DC subpopulations per spleen three
days p.i. with Ye of the indicated mouse strains. The data show the summary
results from three independent experiments with three to 5 mice per group
in each experiment. * indicate statistically significant differences.
doi:10.1371/journal.ppat.1001212.g007
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conventional DCs in the spleen [79]. This suggests, that the higher
proliferation of all DC subpopulations upon Ye infection is due to
an increased differentiation of precursor cells into conventional
DCs. Upon infection of mice with Listeria monocytogenes or Leishmania
major recruited inflammatory monocytes differentiate into Tip-DCs
at sites of infection in a CCR2-dependent manner [80–82].
Interestingly, the observed increased numbers of CD4
2CD8a
2
DCs upon Ye infection do not represent Tip-DCs. Nevertheless,
more detailed studies are needed to uncover the mechanism
responsible for the disturbed CD4
+ DC homeostasis upon Ye
infection. Furthermore, it must be stressed that the observed
changes in DC functions described herein occurred upon infection
with high doses of bacteria; it might well be that the quantity of
bacterial pathogenicity factors operating might be important for
the observed effects.
In summary, this study demonstrates that Ye affects splenic DC
subpopulations in different ways: Ye directly injects Yops into a
Figure 8. Proliferation and recovery of DC subpopulations from mice infected with Ye. (A) C57BL/6 mice were injected i.v. with 5610
4 Ye
pYV
+ or PBS and daily with BrdU. The percentage of BrdU
+ DC subpopulations was analyzed one to three days p.i. by flow cytometry. Data are
representative of 2 independent experiments with 5 mice per group. (B) CD11c.DOG mice were once injected i.p. with diphteria toxin (DT) to ablate
CD11c
hi cells. 24 h later the mice were injected i.v. with 5610
4 Ye pYV
+ or PBS. The absolute numbers of DC subpopulations in the spleen were
analyzed by flow cytometry one to three days p.i.. The data show the summary results from two independent experiments with 4–5 mice per group
in each experiment. (C) CD11c.DOG mice were treated as described in (B). The CD4
2CD8a
2 DCs were analyzed three days p.i. for the indicated
antigens characterizing inflammatory DCs. * indicate statistically significant differences.
doi:10.1371/journal.ppat.1001212.g008
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with Ye leads to a massive reduction of CD4
+ DCs in a TLR4-
and TRIF-dependent manner. Moreover, we cannot exclude that
DC subpopulations are differentially susceptible or resistant to
pathogenicity factors such as Yops of Ye. Nevertheless, the direct
and indirect effects of Ye on DC subpopulations may contribute to
reduced T-cell proliferation and thus immune evasion of the
pathogen.
Our data and published reports (e.g. Mycobacterium tuberculosis,
Salmonella typhimurium, E. coli [15,51,62,83]) suggest that (i) splenic
DC subsets are differentially affected by various bacterial
pathogens, and (ii) primarily indirect effects exerted by systemic
infection contribute to alterations of the majority of DCs in vivo
rather than direct interactions of DCs with pathogens. This
together with different functions of the DC subpopulations leads to
the variability of DC responses to various bacterial infections.
Materials and Methods
Mice and infection
Ethics statement: Animal experiments were performed in strict
accordance with the German regulations of the Society for
Laboratory Animal Science (GV-SOLAS) and the European Health
Law of the Federation of Laboratory Animal Science Associations
(FELASA). The protocol was approved by the Regierungspra ¨si-
dium Tu ¨bingen (Permit Number: IM5/08). All efforts were made
to minimize suffering.
Female C57BL/6JolaHsd mice were purchased from Harlan
Winkelmann (Borchen, Germany). TLR2
2/2xTLR4
2/2, TRIF
2/2
(LPS2) [84], MyD88
2/2 [85], OT-II [43], and CD11c.DOG [56]
mice with a genetic C57BL/6 background were bred under specific
pathogen-free conditions in the animal facilities of the University
Clinic of Tu ¨bingen and the University of Tu ¨bingen. Mice used for
experimentswere between6–9weeksofageand wereprovidedfood
and water ad libitum.
Mice were infected with the indicated amount of Ye WA-314
(serotype 0:8) from frozen stock suspensions in 200 ml PBS into the
tail vein. As a control, mice were infected only with 200 ml PBS.
For the translocation experiments mice were infected with Ye
5610
5 E40-YopE53-blactamase or E40-YopE53-OVA [46] as
control one h after treatment of the mice with 2.5 mg
desferoxamine mesylate salt (Sigma) in PBS i.v.. The bacterial
load in the spleen was assessed after plating serial dilutions of the
cell suspensions obtained on Mu ¨ller-Hinton agar plates and was
comparable for all mouse strains. For systemic DC depletion BAC
transgenic CD11c.DOG mice, that express the human diphtheria
toxin receptor under control of the CD11c promoter, were
injected intraperitoneally with 8 ng/g bodyweight of diphteria
toxin (Sigma) in PBS one day before Ye infection.
Cell preparation
Spleens were cut into small pieces and then digested for 30 min
at 37uC in 2 ml modified RPMI 1640 + 2% FCS medium
containing collagenase (1 mg/ml; type IV; Sigma-Aldrich) and
DNase I (150 mg/ml, Roche). To disrupt DC-T cell complexes,
EDTA (0.1 ml, 0.1 M (pH 7.2)) was added, and mixing continued
for 5 min. Single cell suspensions were made by pipetting the
digested organs. Undigested fibrous material was removed by
filtration and erythrocytes were lysed with lysis buffer (150 mM
NH4Cl, 10 mM KHCO3, 2 mM NaEDTA). The total number of
cells was determined by trypan blue exclusion. Spleen cells were
prepared from individual mice for all experiments except those of
Fig. 1B and 1C. In these experiments, CD11c-expressing cells
were enriched from single cell suspensions of spleen pooled from 3
or 7 mice by MACS technology using N418 magnetic beads
(Miltenyi Biotec) following the manufacturer’s protocol. Cells were
blocked and stained with CD11c-APC, CD4-PE, and CD8a-
FITC in PBS. Then the DC subpopulations were sorted on a
FACS Aria cell sorter (BD Biosciences), reanalyzed on a Canto-II
flow cytometer and used for co-culture experiments in vitro (as
described below).
Flow cytometry
FACS buffer in PBS containing 1% FBS (Sigma-Aldrich) and
0.09% NaN3 (Sigma-Aldrich) was used for all incubations and
washing steps. Before staining, cells were incubated for 15 min at
4uC with hybridoma supernatant from 2.4G2 cell line producing
anti-FcgRII/III mAb. Cells were then stained with FITC, PE,
APC, PE-Cy7, APC-Alexa700, pacific blue, or biotinylated
conjugates of anti-CD11c (HL3, BD Biosciences, Miltenyi Biotec),
CD8a (53-6.7, BD Biosciences), CD4 (RM4-5), CD3 (145.2C11),
CD80 (16-10A1, BD Biosciences), CD86 (GL-1, BD Biosciences),
CD40 (HM40-3, BD Biosciences), MHC II (M5/114.15.2,
eBiosciences) for 20 min at 4uC. To exclude dead cells, 7-
aminoactinomycin D (7-AAD; Sigma-Aldrich) was used in the case
of surface staining and aqua life dead (Invitrogen) in the case of
intracellular cytokine staining. When biotinylated mAb were used,
cells were stained a second time with streptavidin-pacific orange or
streptavidin-PE. To detect intracellular production of TNF, IL-6,
IL-12, cells were seeded at 1610
6 cells/well in low adherence, 24-
well plates (BD Falcon) and incubated for three to four h with
brefeldin A (Biolegend) at a final concentration of 5 mg/ml. Cells
were then stained for surface phenotype, fixed with 1%
paraformaldehyde (Sigma-Aldrich) in PBS, permeabilized with
0,1% saponin (Sigma-Aldrich) and 0,5% BSA (Sigma-Aldrich) in
PBS, and stained for intracellular cytokines with anti-TNF (MP6-
XT22; BD Biosciences), IL-6 (MP5-20F3; Biolegend), IL-12p40
(C15.6; BD Biosciences) for 15 min at 4uC. Samples were acquired
for 6 to 8-colour analysis using a Canto-II flow cytometer (BD
Biosciences) with DIVA software (BD Biosciences) and further
analyzed using FlowJo 7.5 software (TreeStar Inc). A total of
500,000–1,200,000 cells were acquired to ensure the analysis of at
least 8,000 viable splenic DCs in each sample from individual
mice.
For the detection of apoptotic DCs 3610
6 splenocytes were
stained with FITC-Caspases 3 & 7 FLICA Apoptosis Dectection
Kit (Immunohistochemistry Technologies, LLC) according to the
manufacturer’s instructions. Thereafter, cells were stained for cell
surface antigens, measured and analyzed as described above.
For the detection of b-lactamase activity, surface molecule
staining was performed as described above. Then 4610
6 cells were
resuspended in 1x CCF4-AM staining solution supplemented with
probenecid, prepared according to the manufacturer’s instructions
(Invitrogen). Following an incubation of 40 min at room temper-
ature in the dark, cells were measured by flow cytometry on a
Canto-II flow cytometer (BD Biosciences) and analyzed using
FlowJo 7.5 software (Tree Star Inc).
For the detection of the BrdU labeling in vivo mice were daily
injected i.v. with 1.0 mg BrdU (BD Biosciences). Surface molecule
staining of splenocytes was performed as described above. Then
the cells were fixed, permeabilized and BrdU-FITC staining
was performed according to the manufacturer’s protocol (BD
Biosciences).
T cell proliferation assays
CD4
+ T cells were purified from spleen of OT-II mice as
described previously [27] by using the CD4-negative T cell isolation
kit and a magnetic-activated cell sorter system (Miltenyi Biotec).
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+ T
cells, were washed twice with ice-cold PBS, incubated with CFSE
(5 mM; Invitrogen) in PBS for 5 min at room temperature, and then
washed twice with ice-cold heat-inactivated FBS.
Fortheinvivoproliferation assays, 2610
6CFSE-labeledTcellsper
mouse were adoptively transferred into the tail vain 6–8 h p.i. with
Ye, followed by i.v. injection of ovalbumin protein (500 mg/mouse;
Sigma-Aldrich) 24 h post infection. 96 h later T cell proliferation of
the CFSE-labeled CD4
+ T cells was analyzed by flow cytometry, as
described above, after staining with pacific blue-conjugated anti-
CD4 (eBiosciences), APC-Va2 (eBiosciences), and 7-AAD.
For the in vitro stimulation, 1610
4 CFSE-labeled T cells were co-
incubated with 1610
3 sorted splenic DCs per well in RPMI 1640
medium(Biochrom,Berlin, Germany)supplemented with 10%FBS
(Sigma), 2 mM L-glutamine (Invitrogen), 100 U of penicillin/ml,
100 mg/ml of streptomycin (Biochrom), 50 mM b-mercaptoethanol
(Sigma), 1% (vol/vol) nonessential amino acids (Biochrom), and
1 mM sodium pyruvate (Biochrom) in 96 V-bottom well plates in
the presence of 100 mg/ml ovalbumin protein or 150 ng/ml
OVA323–339 peptide. 72 h post incubation at 37uC cells were
stained as described for the in vivo proliferation assay and acquired
by flow cytometry on a Canto-II (BD Biosciences).
The division index was analyzed using FlowJo Software 7.5. It is
defined as the average number of cell divisions that the responding
cells underwent (excluding undivided cells).
Measurement of antigen uptake and antigen processing
by flow cytometry
For antigen uptake or antigen processing, 100 mg of ovalbumin-
AlexaFluor647 and DQ-ovalbumin (both from Molecular Probes)
were injected into the tail vain of mice infected for one or three days
with Ye as described above. One h later the spleen of the mice was
removed and processed for flow cytometry analyses as described
above. The measurement of antigen uptake or processing was
performed on a FACS Canto II flow cytometer (BD Biosciences)
and analyzed using FlowJo Software 7.5 (Tree Star). The OVA
processing was quantified as the frequency of OVA-Alexa647
+O-
VADQ
+cells/the frequency of OVA-Alexa647
+ cells x 100.
Immunofluorescence of cryosections
Tissues were embedded in the Tissue-Tek OCT compound
(Sakura) and frozen at 280uC, and 5 mm cryostat sections were
prepared. Tissue sections were fixed for 15 min at RT with 4%
paraformaldehyde (TUNEL and CD11c staining) or for 10 min
with ice cold acetone (CD11c staining), washed twice with PBS
and the excess of biotin was blocked with a biotin blocking kit
(Vector). Tissue sections were incubated overnight at 4uC with
biotin-conjugated anti-CD11c antibody (HL3, 5 mg/ml in PBS-
10% FBS), washed and then incubated with streptavidin-
AlexaFluor594 (2.5 mg/ml in PBS-10% FBS) for 1 h at 4uC.
Slides were further treated to visualize apoptotic cells using FITC-
labeled TUNEL kit (Bo ¨hringer Mannheim) according to the
manufacturer’s instructions. Slides were mounted in Mowiol (Carl
Roth). Labeled cells were visualized with a DMRE fluorescence
microscope (Leica) or an Axiovert 200 M fluorescence microscope
(Zeiss).
Statistics
Data were analyzed using the Graph Pad Prism 4.0 software.
Diagrams show mean values + SD, except for Fig. 6C where mean
values + SEM are shown. Statistical analysis was performed using
the unpaired two-tailed Student’s t test. Differences were
considered as statistically significant if p,0.05 (*), p,0.01 (**),
or p,0.005 (***).
Supporting Information
Figure S1 CCF4 stains living cells. Dot plots show untreated and
staurosporine-treated (for three h at 37uC with 6 mM final
concentration) splenocytes from C57BL/6 mice stained with 7-
AAD and CCF4.
Found at: doi:10.1371/journal.ppat.1001212.s001 (0.08 MB TIF)
Figure S2 In vitro Ye infection of spleen cells does not result in
changes of DC subpopulations. Dot plots show splenocytes from
C57BL/6 mice untreated or infected in vitro for three days with Ye
pYV
+ (5610
4 bacteria/spleen) and stained for DC subpopulations
as depicted in Fig. 5A.
Found at: doi:10.1371/journal.ppat.1001212.s002 (0.12 MB TIF)
Figure S3 Gating strategy for 7-AAD
+ and caspases 3/7
+ DCs.
(A) Dot plots show gating of DC subpopulations including dead
cells. (B) Histograms show analysis of 7-AAD
+ DC subpopulations
following the gating strategy shown in (A). The percentage above
the marker was used for statistical analysis in Fig. 5C. Data are
representative for 4 experiments with 5 mice per group. (C) Dot
plots show the analysis of caspases 3/7
+ DC subpopulations
following the gating strategy shown in (A). The sum of the
percentages in the lower right (caspases 3/7
+ cells) and the upper
right (caspases3/7
+7-AAD
+ cells) quadrants was used for statistical
analysis in Fig. 5D. Data are representative for 2 independent
experiments with 5 mice per group.
Found at: doi:10.1371/journal.ppat.1001212.s003 (0.46 MB TIF)
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